Home measurement of 24-hour corticosteroid dynamics in primary aldosteronism
Research Square
2025
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Primary aldosteronism (PA) affects 5–20% of the hypertensive population and is associated with increased cardiovascular and metabolic risks compared with primary hypertension. PA is significantly underdiagnosed partly due to our inability to capture the pulsatile variability of aldosterone over 24 hours in clinical settings. To gain insight into steroid secretion patterns in PA we applied multiplex 24-hour profiling of free corticosteroids concentrations in subcutaneous tissue microdialysate in 60 PA patients and 215 healthy individuals in a home setting (NCT02934399). PA profiles displayed a diurnal, pulsatile hypersecretion of aldosterone compared with healthy participants. Nocturnal and early morning hypersecretion of aldosterone and the hybrid steroids 18-hydroxycortisol and 18-oxocortisol enabled the identification of unilateral PA cases, candidates for surgical treatment. Indeed, normalisation of aldosterone hypersecretion was observed after adrenalectomy. Using dynamic markers extracted from the 24-hour time series our machine learning classifier achieved sensitivity of 88% and specificity of 80% to diagnose PA. We demonstrate that 24-hour dynamic hormone profiling in the home setting has the potential to transform endocrine diagnostics from assessing single point hormone levels to evaluation of dynamic patterns, which can change clinical practice not only for the diagnosis of PA, but also for other hormone excess and deficiency syndromes.
Bibliographic Details
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know